Thrombocytopenia
268 results
101 - 200
Assessment and treatment of a patient with bleeding diathesis - Direct oral anticoagulants
- Brain and spinal cord tumours
- Chronic lymphocytic leukaemia (CLL)
Radioisotopes for metastatic bone pain: Cochrane systematic review- Heparin versus placebo for non‐ST elevation acute coronary syndromes
- Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters
Vitamins C and E ineffective for PIH- Pegylated liposomal doxorubicin for first‐line treatment of epithelial ovarian cancer
- Prophylactic platelet transfusions prior to surgery for people with a low platelet count
- Platinum versus non‐platinum chemotherapy regimens for small cell lung cancer
- Blood transfusion: indications, administration and adverse reactions
- Bone marrow aspiration from sternum - Video
- Bone marrow aspiration from the posterior iliac crest - Video
- Mononucleosis
- Discoid lupus erythematosus
- Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy
- Anticoagulants for people hospitalised with COVID‐19
- Dalteparin = unfractionated heparin for ICU DVT prophylaxis
- Medical treatments for idiopathic thrombocytopenic purpura during pregnancy: Cochrane systematic review
- Unintentional weight loss in adults
- Elevated blood pressure in pregnancy (gestational hypertension, pre-eclampsia)
- HIV infection
- Linezolid versus vancomycin for skin and soft tissue infections
- Increased blood creatinine concentration, eGFR and renal function tests
- Platinum-based chemotherapy regimens for small-cell lung cancer
- AABB recommends restrictive transfusion strategy for hospitalized patients
- Intermediate-dose prophylactic anticoagulation not recommended for patients with COVID-19 in the ICU
- Heparin-bonded catheters for prolonging the patency of central venous catheters in children: Cochrane systematic review
- Myelodysplastic syndromes (MDS)
- Sarcoidosis
- Comparison of a therapeutic‐only versus prophylactic platelet transfusion policy for people with congenital or acquired bone marrow failure disorders
- LMWH better than unfractionated heparin for preventing DVT in medical patients
- Bivalirudin = abciximab + heparin for non-STEMI
- Prevention of venous thromboembolism
- Leucopenia
- Common cold in adults
- Anticoagulation for people with cancer and central venous catheters
- Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients
- Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery
- Systemic treatments for the prevention of venous thrombo‐embolic events in paediatric cancer patients with tunnelled central venous catheters
- Cisplatin versus carboplatin in combination with third‐generation drugs for advanced non‐small cell lung cancer
- Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation
- Parenteral anticoagulation in ambulatory patients with cancer
- Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease
- Intravenous iron versus oral iron versus no iron with or without erythropoiesis‐ stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta‐analysis
- Extracorporeal membrane oxygenation probably does not significantly reduce mortality in severe ARDS
- First-trimester vaginal progesterone results in lower rates of hypertensive disorders of pregnancy and preeclampsia
- Lenalidomide effective for relapsed multiple myeloma
- Romiplostim safe, effective, and very expensive treatment for ITP
- Bortezomib for the treatment of multiple myeloma
- Systemic sclerosis
- Viral diseases in warm climates
- Systemic lupus erythematosus (SLE)
- Tumours of haematopoietic and lymphoid tissues: general information
- Postinfectious syndromes
- Pentasaccharides for the treatment of deep vein thrombosis
- Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery
- Thromboprophylaxis with apixaban prevents VTE in high-risk cancer patients (AVERT); jury still out on rivaroxaban (CASSINI)
- Clinical signs and symptoms not sufficient to diagnose endemic and returning travelers' malaria
- No benefit to extended VTE prophylaxis with apixaban in hospitalized medical patients (ADOPT)
- New classification criteria for SLE
- Thrombopoietin mimetics for patients with myelodysplastic syndromes: Cochrane systematic review
- Multiple myeloma (MM)
- Peripheral blood smear
- Introduction to extra-intestinal protozoal diseases
- Chemotherapy for advanced non‐small cell lung cancer in the elderly population
- Janus kinase‐1 and Janus kinase‐2 inhibitors for treating myelofibrosis
- Better maternal outcomes with testing for placental growth factor when pre-eclampsia is suspected
- New ACR and EULAR criteria for diagnosing SLE
- Clopidogrel + ASA for afib: fewer strokes, more hemorrhages (ACTIVE)
- Warfarin therapy
- Updated American College of Chest Physicians guideline on antithrombotic therapy for venous thromboembolism
- Alemtuzumab more effective than interferon for multiple sclerosis
- Partial exchange transfusion to prevent neurodevelopmental disability in infants with polycythemia
- A therapeutic‐only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation
- Cyclophosphamide for connective tissue disease–associated interstitial lung disease
- Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters: Cochrane systematic review
- Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients
- Cyclophosphamide for treating rheumatoid arthritis
- Prophylactic antibiotics or G(M)‐CSF for the prevention of infections and improvement of survival in cancer patients receiving myelotoxic chemotherapy
- Transfusion thresholds for guiding allogeneic red blood cell transfusion
- Adder (Vipera berus) bite
- Infections in immunosuppressed and cancer patients
- Bacterial diseases in warm climates
- Heparin for the treatment of thrombosis in neonates